A Phase 1, Single-Centre, Randomised, Double-Blind (Within Panels), Placebo-Controlled Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1704 After Administration of Oral Single Ascending Doses in Healthy Japanese Male and Non-Fertile Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2010
At a glance
- Drugs AZD 1704 (Primary)
- Indications Pain
- Focus Adverse reactions
- 09 Dec 2010 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 18 Dec 2008 Planned number of patients changed from 64 to 16 as reported by ClinicalTrials.gov.
- 21 Oct 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.